The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
BENZOFURANE DERIVATIVES FOR THE TREATMENT OF HEPATITITS C
申请人:Bristol-Myers Squibb Company
公开号:EP2649067A1
公开(公告)日:2013-10-16
US8507683B2
申请人:——
公开号:US8507683B2
公开(公告)日:2013-08-13
[EN] BENZOFURANE DERIVATIVES FOR THE TREATMENT OF HEPATITITS C<br/>[FR] DÉRIVÉS DE BENZOFURANE POUR LE TRAITEMENT DE L'HÉPATITE C
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2012078545A1
公开(公告)日:2012-06-14
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.